Verapamil inhibits mediator release from human lung in vitro.
作者信息
Lee V Y, Hughes J M, Seale J P, Temple D M
出版信息
Thorax. 1983 May;38(5):386-7. doi: 10.1136/thx.38.5.386.
Abstract
摘要
相似文献
1
Verapamil inhibits mediator release from human lung in vitro.维拉帕米在体外抑制人肺中介质的释放。
Thorax. 1983 May;38(5):386-7. doi: 10.1136/thx.38.5.386.
2
Inhibitory action of verapamil and chlorpromazine on the release of slow-reacting substance of anaphylaxis from cat lung.维拉帕米和氯丙嗪对猫肺过敏反应慢反应物质释放的抑制作用。
Pharmacol Res Commun. 1986 Nov;18(11):1043-52. doi: 10.1016/0031-6989(86)90021-4.
3
Effects of sodium cromoglycate analogues on the immunological release of slow reacting substance of anaphylaxis and histamine from human and guinea-pig lung in vitro.色甘酸钠类似物对人及豚鼠肺组织在体外免疫释放过敏反应慢反应物质和组胺的影响。
J Pharm Pharmacol. 1982 Jun;34(6):401-2. doi: 10.1111/j.2042-7158.1982.tb04741.x.
4
Selective inhibition by betamethasone of allergen-induced release of SRS-A from human lung.倍他米松对变应原诱导的人肺组织中慢反应物质-A释放的选择性抑制作用。
Int Arch Allergy Appl Immunol. 1982;67(3):284-6. doi: 10.1159/000233032.
5
Ranitidine does not potentiate mediator release from human lung in vitro.雷尼替丁在体外不会增强人肺中介质的释放。
Br J Clin Pharmacol. 1985 May;19(5):711-2. doi: 10.1111/j.1365-2125.1985.tb02702.x.
6
Effects of a 5-lipoxygenase inhibitor, REV-5901, on leukotriene and histamine release from human lung tissue in-vitro.5-脂氧合酶抑制剂REV-5901对人肺组织体外白三烯和组胺释放的影响。
J Pharm Pharmacol. 1987 Apr;39(4):309-11. doi: 10.1111/j.2042-7158.1987.tb06274.x.
7
[Inhibition of anaphylactic chemical mediator release by tranilast].曲尼司特对过敏反应化学介质释放的抑制作用
Arerugi. 1987 Oct;36(10):937-42.
8
9
[Inhibition of chemical mediator release from human leukocytes and lung fragments by TBX].[TBX对人白细胞和肺组织碎片中化学介质释放的抑制作用]
Arerugi. 1988 Jul;37(7):438-47.
10
[Effect of aspirin and indomethacin on the immunological release of histamine and slow reacting substance of anaphylaxis (SRS-A) from guinea-pig lung tissues (author's transl)].阿司匹林和消炎痛对豚鼠肺组织中组胺和过敏反应慢反应物质（SRS-A）免疫释放的影响（作者译）
Nihon Kyobu Shikkan Gakkai Zasshi. 1980 May;18(5):317-21.
引用本文的文献
1
Calcium-channel blockers and asthma.钙通道阻滞剂与哮喘
Thorax. 1983 Jul;38(7):481-5. doi: 10.1136/thx.38.7.481.
2
Inhibition of allergic and non-allergic histamine secretion from rat peritoneal mast cells by calcium antagonists.钙拮抗剂对大鼠腹膜肥大细胞过敏和非过敏组胺分泌的抑制作用。
Br J Pharmacol. 1984 Dec;83(4):899-902. doi: 10.1111/j.1476-5381.1984.tb16529.x.
3
Relative activities of three calcium channel antagonists on histamine, acetylcholine and antigen-induced contractions of guinea pig ileum.三种钙通道拮抗剂对组胺、乙酰胆碱及抗原诱导的豚鼠回肠收缩的相对活性。
Agents Actions. 1985 Dec;17(2):113-20. doi: 10.1007/BF01966578.
4
Clinical studies with calcium antagonists in asthma.钙拮抗剂在哮喘中的临床研究。
Br J Clin Pharmacol. 1985;20 Suppl 2(Suppl 2):289S-298S. doi: 10.1111/j.1365-2125.1985.tb02815.x.
5
Inhibition of phospholipase A2 (PLA2) activity by nifedipine and nisoldipine is independent of their calcium-channel-blocking activity.硝苯地平和尼索地平对磷脂酶A2（PLA2）活性的抑制作用与其钙通道阻滞活性无关。
Inflammation. 1987 Sep;11(3):353-64. doi: 10.1007/BF00915839.
6
Heterogeneity of calcium channels in mast cells and basophils and the possible relevance to pathophysiology of lung diseases: a review.肥大细胞和嗜碱性粒细胞中钙通道的异质性及其与肺部疾病病理生理学的可能关联：综述
Agents Actions. 1986 Mar;17(5-6):407-17. doi: 10.1007/BF01965507.
7
Calcium channel blockers and asthma.钙通道阻滞剂与哮喘
Lung. 1986;164(1):1-16. doi: 10.1007/BF02713625.
8
Inhibition of histamine release from dispersed human lung and tonsillar mast cells by nicardipine and nifedipine.尼卡地平与硝苯地平对人肺和扁桃体分散肥大细胞组胺释放的抑制作用。
Br J Clin Pharmacol. 1985 May;19(5):631-8. doi: 10.1111/j.1365-2125.1985.tb02690.x.
本文引用的文献
1
Nomenclature for leukotrienes.白三烯的命名法。
Prostaglandins. 1980 May;19(5):645-8. doi: 10.1016/0090-6980(80)90099-4.
2
The effect of verapamil on histamine and methacholine-induced bronchoconstriction.维拉帕米对组胺和乙酰甲胆碱诱导的支气管收缩的影响。
Clin Allergy. 1981 Sep;11(5):441-7. doi: 10.1111/j.1365-2222.1981.tb01617.x.
3
Inhibition of exercise-induced asthma by a calcium antagonist, nifedipine.钙拮抗剂硝苯地平对运动诱发性哮喘的抑制作用。
Am Rev Respir Dis. 1981 Feb;123(2):156-60. doi: 10.1164/arrd.1981.123.2.156.
4
A calcium antagonist, nifedipine, modifies exercise-induced asthma.钙拮抗剂硝苯地平可改善运动诱发的哮喘。
Thorax. 1981 Oct;36(10):726-30. doi: 10.1136/thx.36.10.726.
5
Calcium antagonists in exercise-induced asthma.运动诱发性哮喘中的钙拮抗剂
Br Med J (Clin Res Ed). 1981 Mar 21;282(6268):932-3. doi: 10.1136/bmj.282.6268.932.
6
Effect of lipoxygenase inhibitors on release of slow-reacting substances from human lung.脂氧合酶抑制剂对人肺中慢反应物质释放的影响。
Eur J Pharmacol. 1981 Jun 10;72(1):93-6. doi: 10.1016/0014-2999(81)90302-2.
7
The role of calcium in the generation of intracellular SRS-A in passively sensitized human lung challenged with antigen.钙在抗原激发的被动致敏人肺组织中细胞内慢反应物质A生成过程中的作用。
Clin Allergy. 1980 Sep;10(5):565-73. doi: 10.1111/j.1365-2222.1980.tb02138.x.
8
The role of slow-reacting substance in asthma.慢反应物质在哮喘中的作用。
Adv Drug Res. 1970;5:109-13.
9
Effects of local anaesthetics on prostaglandin biosynthesis in vitro.局部麻醉药对体外前列腺素生物合成的影响。
Biochim Biophys Acta. 1974 Sep 19;360(3):260-9. doi: 10.1016/0005-2760(74)90055-1.
10
Physiological disposition of verapamil in man.维拉帕米在人体中的生理分布。
Cardiovasc Res. 1976 Sep;10(5):605-12. doi: 10.1093/cvr/10.5.605.
Zotero 插件